Do not repeat esophagogastroduodenoscopy (EGD) in patients diagnosed with gastroesophageal reflux disease (GERD), unless the examination is part of the follow-up of precancerous epithelial conditions (Barrett’s esophagus) or in the event of new alarm symptoms.

Do not repeat esophagogastroduodenoscopy (EGD) in patients diagnosed with gastroesophageal reflux disease (GERD), unless the examination is part of the follow-up of precancerous epithelial conditions (Barrett’s esophagus) or in the event of new alarm symptoms.

Endoscopy in gastroesophageal reflux disease (GERD) should be reserved for patients who do not respond to an 8-week course of empirical therapy with proton pump inhibitors, for patients with extraesophageal symptoms that do not respond to therapy, for those presenting...